Table 2.
Association between mold exposure and parent-reported doctor-diagnosed AD at 1 year of age according to the time of exposure.
| Time of mold exposure | AD, n (%) | OR (95% CI) |
AD, n (%) | aORa (95% CI) |
AD, n (%) | aORb | |
|---|---|---|---|---|---|---|---|
| During pregnancy | (−) | 186/1065 (17.5) | 1 | 179/1016 (17.6) | 1 | 179/1016 (17.6) | 1 (ref.) |
| (+) | 85/381 (22.3) | 1.36 (1.02–1.81) | 83/369 (22.5) | 1.36 (1.01–1.83) | 83/369 (22.5) | 1.36 (1.01–1.83) | |
| During the first 6 months of life | (−) | 187/921 (20.3) | 1 | 178/871 (20.4) | 1 | 178/871 (20.4) | 1 (ref.) |
| (+) | 73/421 (17.3) | 0.82 (0.61–1.11) | 72/407 (17.7) | 0.83 (0.61–1.13) | 72/407 (17.7) | 0.83 (0.61–1.13) |
Data are presented as n or %. AD, atopic dermatitis.
Bold significance means that the risk of AD was increased in infants with mold exposure during the prenatal period, compared with those without mold exposure during the prenatal period using logistic regression model.
a
Adjusted for maternal age, maternal body mass index, maternal education level, child's gender, parental history of allergic disease, and birth season.
b
Adjusted for maternal age, maternal body mass index, maternal education level, child's gender, parental history of allergic disease, birth season, and prenatal or postnatal mold exposure.